- List of pharmaceutical companies
-
The following is a list of the twelve largest healthcare companies ranked here by revenue as of March 2010[update] according to their released 2009 annual reports.
Rank Company Country Total Revenues (USD billions) Total Revenues (reported currency in millions) Change 09/08 (%) Net income/ (loss) (reported currency in millions) Change 09/08 (%) R&D Expenses (reported currency in millions) Change 09/08 (%) Fortune 500 Ranking[1] 1 Johnson & Johnson[2] United States 61,90[3] $61,897 -2.9 $12,266 -5.3 6,986 -7.8 103 2 Pfizer[4] United States 50,01[3] $50,009 3.5 8,635 6.6 7,845 -1.3 152 3 Roche[5] Switzerland 47,35[3] 49,051 CHF 7.5 8,510 CHF -21.5 9,874 CHF 11.6 171 4 GlaxoSmithKline[6] United Kingdom 45,83[3] £28,368 16.5 £5,669 20.3 £4,106 11.5 168 5 Novartis[7] Switzerland 44,27[3] $44,267 6.8 $8,454 3.6 $7,469 3.5 183 6 Sanofi[8] France 41,99[3] €29,306 6.3 €8,471 17.9 €4,583 0.2 181 7 AstraZeneca[9] United Kingdom 32,81[10] $32,804 3.8 $7,544 23.1 $4,409 -14.9 268 8 Abbott Laboratories[11] United States 30,76[10] $30,765 4.2 5,746 21.4 2,744 2.1 294 9 Merck & Co.[12] United States 27,43[10] $27,428 15.0 $13,024 64.2 $5,800 20.8 378 10 Bayer HealthCare[13] Germany 22,30 €15,988 3.8 €1,696 38.8 €1,845 5.9 154 11 Eli Lilly[14] United States 21,84[15] $21,836 7.2 $4,328 N/A N/A N/A 455 12 Bristol-Myers Squibb[16] United States 18,81[17] $18,808 6.2 $4,420 19.9 3,647 3.8 435 Some data have not been audited yet. Bayer has additional revenue not included here. The missing parts of the table will be added as more data are released by the companies.
The following is a list of the twelve largest healthcare companies ranked by revenue as of July 2009[update] in the Fortune Global 500.[1]
Rank[1] Company Country Total Revenues (USD millions) Net income/ (loss) (USD millions) Employees 1 Johnson & Johnson United States 63,747.0[18] 12,949.0 118,700 2 Pfizer United States 48,296.0[19] 8,104.0 81,800 3 GlaxoSmithKline United Kingdom 44,654.0[20] 8,438.6 99,003 4 Roche Switzerland 44,267.5[21] 8,288.1 80,080 5 Sanofi-Aventis France 42,179.0[22] 5,636.7 98,213 6 Novartis Switzerland 41,459.0[23] 8,195.0 96,717 7 AstraZeneca United Kingdom 31,601.0[24] 6,101.0 65,000 8 Abbott Laboratories United States 29,527.6[25] 4,880.7 68,838 9 Merck United States 23,850.3[26] 7,808.4 55,200 10 Wyeth United States 22,833.9[27] 4,417.8 47,426 11 Bristol-Myers Squibb United States 21,366.0[28] 5,247.0 35,000 12 Eli Lilly United States 20,378.0[29] (2,071.9) 40,500 The following is a list of the 49 largest companies involved in pharmaceutical and biotech industry ranked by healthcare revenue as of 2008[update].[30] Some companies (e.g., Bayer) has additional revenue not included here.[31][32]
Rank[30] Company Country Total Revenues (USD millions) Healthcare R&D 2008 (USD millions) Net income/ (loss) 2008 (USD millions) Employees 2008 1 Pfizer[33] (with Wyeth[34]) United States 70,696 11,318 14,111 137,127 2 Johnson & Johnson United States 63,747 NA 10,576 119,200 3 Hoffmann–La Roche Switzerland 43,970 NA 8,135 78,604 4 Novartis Switzerland 41,460 NA 11,946 98,200 5 GlaxoSmithKline United Kingdom 40,424 6,373 10,432 103,483 6 Sanofi-Aventis France 40,328 NA 7,204 99,495 7 AstraZeneca United Kingdom 31,601 NA 5,959 67,400 8 Abbott Laboratories[35] United States 29,527 2,688 4,880 68,697 9 Merck & Co. United States 23,850 4,678 7,808 74,372 10 Bristol-Myers Squibb United States 19,977 NA 2,165 42,000 11 Eli Lilly and Company United States 18,634 NA 2,953 40,600 12 Boehringer Ingelheim Germany 16,959 1,977 2,163 43,000 13 Takeda Pharmaceutical Co. Japan 15,697 1,620 2,870 15,000 14 Bayer [36] Germany 15,407 3,770 6,448 108,600 15 Amgen United States 14,771 3,366 3,166 48,000 16 Genentech United States 13,400 15773 3,640 33,500 17 Baxter International United States 12,300 614 1,397 38,428 18 Teva Pharmaceutical Industries Israel 11,080 495 546 26,670 19 Astellas Pharma Japan 10,701 1,435 1,122 23,613 20 Daiichi Sankyo Japan 9,682 1,459 671 20,100 21 Novo Nordisk Denmark 9,081 1,063 1,922 26,575 22 Procter & Gamble United States 8,964 NA 10,340 29,258 23 Eisai Japan 5,583 926 604 14,993 24 Merck KGaA Germany 5,175 772 1,258 13,900 25 Alcon United States 4,897 512 1,348 13,500 26 SINOPHARM China 4,700 498 1249 9700 27 Akzo Nobel Netherlands 4,694 741 1,449 13,000 28 UCB Belgium 4,426 1,024 492 12,741 29 Nycomed Switzerland 4,264 NA -105 10,533 30 Forest Laboratories United States 3,442 941 454 9,649 31 Solvay Belgium 3,268 533 1,026 9,000 32 Genzyme United States 3,187 650 -17 8,477 33 Allergan United States 3,063 1,056 -127 8,423 34 Gilead Sciences United States 3,026 384 -1,190 6,772 35 CSL Australia 2,788 161 454 6,400 36 Chugai Pharmaceutical Co. Japan 2,787 467 328 5,962 37 Biogen Idec United States 2,683 718 218 5,907 38 Bausch & Lomb United States 2,292 197 15 5,830 39 Taiho Pharmaceutical Co. Japan 2,069 244 132 5,756 40 King Pharmaceuticals United States 1,989 254 289 5,191 41 Watson Pharmaceuticals United States 1,979 131 -445 5,126 42 Mitsubishi Pharma Japan 1,945 403 208 5,111 43 Shire United Kingdom 1,797 387 278 4,958 44 Cephalon United States 1,764 403 145 4,913 45 Dainippon Sumitomo Pharma Japan 1,763 350 193 3,750 46 Kyowa Hakko Japan 1,698 268 108 2,895 47 Shionogi Japan 1,640 320 159 2,868 48 Mylan Laboratories United States 1,612 104 217 2,800 49 H. Lundbeck Denmark 1,552 329 186 2,515 Contents
Alphabetical listing
- It is limited to those companies notable enough to have articles in Wikipedia.
1-A
- 3M Pharmaceuticals
- Abbott Laboratories
- Actavis
- Actelion
- Alcon
- Alkaloid
- Alkermes
- Allergan
- Almirall
- Alphapharm, a wholly owned subsidiary of Merck KGaA.
- Altana Pharma AG, formerly part of Altana AG, part of the Nycomed Group.
- Amgen
- Amico Laboratories
- Anavex Life Sciences
- Apotex Inc.
- Astellas Pharma
- AstraZeneca
- Avax Technologies
- Axcan Pharma
B-D
- Bargn Farmaceutici Phils Co
- Barr
- Bausch & Lomb
- Baxter International
- Bayer Schering Pharma AG
- Beximco Pharmaceuticals Ltd
- Bial
- Biogen Idec, merger of Biogen and Idec Pharmaceuticals.
- Biolex
- Bionovo
- Biotecnol
- Biovail
- Biovitrum
- Boehringer-Ingelheim
- Bosnalijek
- Bristol-Myers Squibb
- Cadila Healthcare
- Celgene
- Cephalon
- Chugai Pharmaceutical Co.
- Cipla
- Covance
- Covidien
- Crucell
- CSL Limited
- Daiichi Sankyo
- Dainippon Sumitomo Pharma
- Dawakhana Shifaul Amraz
- Debiopharm
- Diabetology Ltd
- Dr. Reddy's Laboratories
E-J
- Ego Pharmaceuticals
- Eisai (company)
- Élan Corporation
- Eli Lilly and Company
- Elorac, Inc.
- Emergent BioSolutions
- Eskayef Bangladesh Limited
- F. Hoffmann–La Roche Ltd., which owns Genentech and Chugai Pharmaceuticals
- Ferozsons Laboratories
- Ferring Pharmaceuticals
- Forest Laboratories
- Fresenius Medical Care
- Galapagos NV
- Galderma Laboratories
- Genentech, a subsidiary of Hoffmann-La Roche
- Genzyme
- Goodwin Biotechnology
- Gulf Pharmaceutical Industries (Julphar)
- Getz Pharma
- Gilead Sciences
- GlaxoSmithKline
- GPC Biotech
- Hetero Drugs
- Hexal Australia
- Hikma Pharmaceuticals
- Hoffmann–La Roche
- Hospira
- IMULAN BioTherapeutics, LLC
- Institute for OneWorld Health
- Intas Biopharmaceuticals
- Intercytex
- Interphil Laboratories
- Janssen Pharmaceutica Products, a subsidiary of Johnson & Johnson
- Jenapharm, a subsidiary of Bayer Schering Pharma
- JN-International Medical Corporation
- Johnson & Johnson
K-L
- King Pharmaceuticals
- Krka, d. d.
- Kyowa Hakko
- Lundbeck
- Lupin Laboratories
M
N
O
- Orion Pharma
- Ortho-McNeil Pharmaceutical, a subsidiary of Johnson & Johnson
- Otsuka Pharmaceutical Co.
P
- Panacea Biotec Ltd
- Patheon
- Par Pharmaceutical
- Perrigo
- Pfizer
- Pharmacosmos
- Pharma Nord
- Pierre Fabre Group
- Piramal Healthcare
- Pliva
- Procter & Gamble
- Purdue Pharma
R
- Ranbaxy Laboratories, generics arm of Daiichi Sankyo
- Renovo
- Respa Pharmaceuticals
- Rubicon Research
S
- Sanofi-Aventis
- Square Pharmaceuticals
- Schering-Plough
- Sepracor
- Servier Laboratories
- Shionogi
- Shire plc
- Sigma Pharmaceuticals
- Sinopharm Group
- Solvay Group
- STADA Arzneimittel
- Strides Arcolab
- Sun Pharmaceutical
T
- Taiho Pharmaceutical
- Takeda Pharmaceutical Company
- TAP Pharmaceutical Products, a joint-venture of Abbott and Takeda.
- Temmler
- Teva Pharmaceutical Industries
- Torrent Pharmaceuticals
U-Z
- UCB
- UNILAB, also known as United Laboratories
- Valeant Pharmaceuticals International, formerly ICN Pharmaceuticals.
- Veloxis Pharmaceuticals
- Vertex Pharmaceuticals
- Vion Pharmaceuticals, Inc.
- ViroPharma
- Warner Chilcott
- Watson Pharmaceuticals
- Wockhardt
- Wyeth, a subsidiary of Pfizer
- Zandu Pharmaceuticals
- Zentiva
See also
- EuropaBio, the European Association for Bioindustries
- European Confederation of Pharmaceutical Entrepreneurs
- European Federation of Pharmaceutical Industries and Associations (EFPIA)
- History of pharmacy
- International Federation of Pharmaceutical Manufacturers and Associations
- List of biotechnology companies
- List of pharmaceutical manufacturers in the UK
- Pharmaceutical Research and Manufacturers of America (PhRMA)
References
- ^ a b c "Fortune Global 500 2009 Pharmeceutical Industry". Fortune 160 (2). July 2009. http://money.cnn.com/magazines/fortune/global500/2009/industries/21/index.html. Retrieved 2009-12-18.
- ^ Johnson & Johnson Reports 2009 Fourth-Quarter and Full-Year Results. 2010. http://www.jnj.com/connect/news/financial/20100125_130000. Retrieved 2010-03-02.
- ^ a b c d e f The Global 2000. 2010. http://www.forbes.com/lists/2010/18/global-2000-10_The-Global-2000_Sales_2.html. Retrieved 2010-08-15.
- ^ 2009 Pfizer Financial Report. 2010. http://www.pfizer.com/investors/financial_reports/financial_reports.jsp. Retrieved 2010-03-02.
- ^ 09 Roche in Brief. 2010. http://www.roche.com/rib_2009.pdf. Retrieved 2010-03-02.
- ^ Annual Reports. 2010. http://www.gsk.com/investors/annual-reports.htm. Retrieved 2010-03-02.
- ^ Annual Report 2009. 2010. http://ir2.flife.de/data/novartis2009/igb_html/index.php?bericht_id=1000002&index=1&lang=ENG. Retrieved 2010-03-02.
- ^ Annual Results 2009. 2010. http://en.sanofi-aventis.com/investors/events/corporate/2010/2010-02-10_results_2009.asp. Retrieved 2010-03-02.
- ^ Condensed Consolidated Statement of Comprehensive Income. 2010. http://www.astrazeneca.com/_mshost3690701/content/resources/media/investors/8270994/figures-fy09.pdf. Retrieved 2010-03-02.
- ^ a b c The Global 2000. 2010. http://www.forbes.com/lists/2010/18/global-2000-10_The-Global-2000_Sales_3.html. Retrieved 2010-08-15.
- ^ Annual Report 2009. 2010. http://www.abbott.com/annual-reports/2009/index.html. Retrieved 2010-04-29.
- ^ Merck Announces Fourth-Quarter and Full-Year 2009 Financial Results. Merck & Co.. 2009-07-20. http://www.merck.com/newsroom/news-release-archive/financial/2010_0216.html. Retrieved 2010-02-12.
- ^ Annual Report 009. 2010. http://www.annualreport2009.bayer.com/en/homepage.aspx. Retrieved 2010-03-02.
- ^ Lilly Reports Fourth-Quarter and Full-Year 2009 Results. 2010. http://newsroom.lilly.com/releasedetail.cfm?ReleaseID=441003. Retrieved 2010-03-02.
- ^ The Global 2000. 2010. http://www.forbes.com/lists/2010/18/global-2000-10_The-Global-2000_Sales_4.html. Retrieved 2010-08-15.
- ^ 2009 Annual Report. 2010. http://thomson.mobular.net/thomson/7/3058/4163/document_0/BMS_AR09.pdf. Retrieved 2010-04-29.
- ^ The Global 2000. 2010. http://www.forbes.com/lists/2010/18/global-2000-10_The-Global-2000_Sales_5.html. Retrieved 2010-08-15.
- ^ "Johnson & Johnson - JNJ". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/235.html. Retrieved 2010-02-12.
- ^ "Pfizer - PFE". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/324.html. Retrieved 2010-02-12.
- ^ "GlaxoSmithKline - GSK". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/6782.html. Retrieved 2010-02-12.
- ^ "Roche Group - RHHVF". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/6798.html. Retrieved 2010-02-12.
- ^ "Sanofi-Aventis - SNY". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/11156.html. Retrieved 2010-02-12.
- ^ "Novartis - NVS". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/6799.html. Retrieved 2010-02-12.
- ^ "AstraZeneca - AZN". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/10022.html. Retrieved 2010-02-12.
- ^ "Abbott Laboratories - ABT". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/4.html. Retrieved 2010-02-12.
- ^ "Merck - MRK". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/280.html. Retrieved 2010-02-12.
- ^ "Wyeth - WYE". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/22.html. Retrieved 2010-02-12.
- ^ "Bristol-Myers Squibb - BMY". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/64.html. Retrieved 2010-02-12.
- ^ "Eli Lilly - LLY". Fortune. 2009-07-20. http://money.cnn.com/magazines/fortune/global500/2009/snapshots/259.html. Retrieved 2010-02-12.
- ^ a b "Global 500". CNN. 2008. http://money.cnn.com/magazines/fortune/global500/2008/index.html. Retrieved 2009-07-27.
- ^ Company Structure. 2009. http://www.jnj.com/connect/about-jnj/company-structure/?flash=true. Retrieved 2010-03-03.
- ^ Profile and Organization. 2010-01-01. http://www.bayer.com/en/Profile-and-Organization.aspx. Retrieved 2010-03-03.
- ^ "Pfizer Annual Report" (PDF). 2008. http://media.pfizer.com/files/annualreport/2008/annual/review2008.pdf. Retrieved 2009-07-24.
- ^ "Wyeth Annual Report" (PDF). 2008. http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9ODM4NnxDaGlsZElEPS0xfFR5cGU9Mw==&t=1. Retrieved 2009-07-24.
- ^ "Abbott Annual Report" (PDF). 2008. http://www.abbott.com/static/content/microsite/annual_report/2008/support_files/ABT_AR_08_onlinefull.pdf. Retrieved 2009-07-24.
- ^ "Kennzahlen Bayer Konzern". 2008. http://www.geschaeftsbericht2008.bayer.de/de/Kennzahlen.aspx. Retrieved 2009-07-27.
Categories:- Pharmaceutical companies
- Pharmaceutical sciences
- Lists of companies by industry
Wikimedia Foundation. 2010.